Johnson & Johnson Q2 2024 Adj EPS $2.82 Beats $2.70 Estimate, Sales $22.447B Beat $22.306B Estimate
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson reported Q2 2024 adjusted EPS of $2.82, beating the estimate of $2.70. Sales were $22.447 billion, surpassing the expected $22.306 billion.
July 17, 2024 | 10:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson's Q2 2024 earnings and sales both exceeded analyst expectations, with EPS at $2.82 versus the $2.70 estimate and sales at $22.447 billion versus the $22.306 billion estimate.
The better-than-expected earnings per share (EPS) and sales figures are likely to positively impact Johnson & Johnson's stock price in the short term as they indicate strong financial performance.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100